1. Home
  2. ABUS vs PEO Comparison

ABUS vs PEO Comparison

Compare ABUS & PEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABUS
  • PEO
  • Stock Information
  • Founded
  • ABUS N/A
  • PEO 1929
  • Country
  • ABUS United States
  • PEO United States
  • Employees
  • ABUS N/A
  • PEO N/A
  • Industry
  • ABUS Biotechnology: Pharmaceutical Preparations
  • PEO Finance/Investors Services
  • Sector
  • ABUS Health Care
  • PEO Finance
  • Exchange
  • ABUS Nasdaq
  • PEO Nasdaq
  • Market Cap
  • ABUS 629.1M
  • PEO 596.4M
  • IPO Year
  • ABUS N/A
  • PEO N/A
  • Fundamental
  • Price
  • ABUS $3.42
  • PEO $22.58
  • Analyst Decision
  • ABUS Strong Buy
  • PEO
  • Analyst Count
  • ABUS 4
  • PEO 0
  • Target Price
  • ABUS $5.50
  • PEO N/A
  • AVG Volume (30 Days)
  • ABUS 646.4K
  • PEO 35.4K
  • Earning Date
  • ABUS 03-03-2025
  • PEO 01-01-0001
  • Dividend Yield
  • ABUS N/A
  • PEO 5.93%
  • EPS Growth
  • ABUS N/A
  • PEO N/A
  • EPS
  • ABUS N/A
  • PEO N/A
  • Revenue
  • ABUS $6,742,000.00
  • PEO N/A
  • Revenue This Year
  • ABUS N/A
  • PEO N/A
  • Revenue Next Year
  • ABUS N/A
  • PEO N/A
  • P/E Ratio
  • ABUS N/A
  • PEO N/A
  • Revenue Growth
  • ABUS N/A
  • PEO N/A
  • 52 Week Low
  • ABUS $2.30
  • PEO $19.22
  • 52 Week High
  • ABUS $4.72
  • PEO $23.80
  • Technical
  • Relative Strength Index (RSI)
  • ABUS 54.07
  • PEO 51.74
  • Support Level
  • ABUS $3.24
  • PEO $22.38
  • Resistance Level
  • ABUS $3.44
  • PEO $22.97
  • Average True Range (ATR)
  • ABUS 0.12
  • PEO 0.37
  • MACD
  • ABUS 0.01
  • PEO 0.06
  • Stochastic Oscillator
  • ABUS 55.56
  • PEO 69.77

About ABUS Arbutus Biopharma Corporation

Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. The company is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.

About PEO Adams Natural Resources Fund Inc.

Adams Natural Resources Fund Inc is a closed-end equity investment company specializing in energy and other natural resources stocks. The investment objectives of the fund are the preservation of capital, the attainment of reasonable income from investments, and an opportunity for capital appreciation. Its portfolio of investments comprises of different sector investments such as in the energy sector and basic materials.

Share on Social Networks: